Search Results - "Pop-Busui R"

The Influence of the Brain-Derived Neurotropic Factor Val66Met -Genotype and HMG-CoA Reductase Inhibitors on Insulin Resistance in the Schizophrenia and Bipolar Populations.

Authors: Burghardt, K.J. Pop-Busui, R. Bly, M.J. et al.

Source: CTS: Clinical & Translational Science. Dec2012, Vol. 5 Issue 6, p486-490. 5p. 2 Charts, 1 Graph.

Cardiac autonomic neuropathy in diabetes: a clinical perspective.

Authors: Pop-Busui R Pop-Busui, Rodica

Source: Diabetes Care. Feb2010, Vol. 33 Issue 2, p434-441. 8p.

Does lamotrigine alleviate the pain in diabetic neuropathy?

Authors: Pop-Busui, R.¹

Source: Nature Clinical Practice Neurology. Aug2007, Vol. 3 Issue 8, p424-425. 2p.

Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes.

Authors: McGuire, D. K. Marx, N. Mulvagh, S. L. et al.

Source: New England Journal of Medicine. 5/29/2025, Vol. 392 Issue 20, p2001-2012. 12p.

Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications.

Authors: Herman, W. H. Pop-Busui, R. Braffett, B. H. et al.

Source: Diabetic Medicine. Jul2012, Vol. 29 Issue 7, p937-944. 0p. 2 Charts, 1 Graph.

Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT/EDIC study.

Authors: Martin CL Waberski BH Pop-Busui R et al.

Source: Diabetes Care. Dec2010, Vol. 33 Issue 12, p2635-2641. 7p.

Subclinical neuropathy among Diabetes Control and Complications Trial participants without diagnosable neuropathy at trial completion: possible predictors of incident neuropathy?

Authors: Albers JW Herman WH Pop-Busui R et al.

Source: Diabetes Care. Oct2007, Vol. 30 Issue 10, p2613-2618. 6p.

URL: 27138393

Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab).

Authors: Biessels, G.J. Bril, V. Calcutt, N.A. et al.

Source: Journal of the Peripheral Nervous System. Jun2014, Vol. 19 Issue 2, p77-87. 11p.

Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes.

Authors: Doria, A. Galecki, A. T. Spino, C. et al.

Source: New England Journal of Medicine. 6/25/2020, Vol. 382 Issue 26, p2493-2503. 11p.

Where does spinal cord stimulation fit into the international guidelines for refractory painful diabetic neuropathy? a consensus statement.

Authors: Boulton, A.J.M. Jensen, T.S. Luecke, T. et al.

Source: Diabetes Research & Clinical Practice. 2023 Supplement 1, Vol. 206, pN.PAG-N.PAG. 1p.

HbA1c is associated with sural nerve regeneration and degeneration in diabetic neuropathy.

Authors: Hur, J. Sullivan, K.A. Pop-Busui, R. et al.

Source: Journal of the Neurological Sciences. Oct2013, Vol. 333, pe697-e698. 0p.

Translating glucose variability metrics into the clinic via Continuous Glucose Monitoring: a Graphical User Interface for Diabetes Evaluation (CGM-GUIDE©).

Authors: Rawlings RA Shi H Yuan LH et al.

Source: Diabetes Technology & Therapeutics. 2011 Dec, Vol. 13 Issue 12, p1241-1248. 8p.

Evaluation of hemoglobin A1c criteria to assess preoperative diabetes risk in cardiac surgery patients.

Authors: Gianchandani RY Saberi S Zrull CA et al.

Source: Diabetes Technology & Therapeutics. 2011 Dec, Vol. 13 Issue 12, p1249-1254. 6p.

Triglycerides and amputation risk in patients with diabetes: ten-year follow-up in the DISTANCE study.

Authors: Callaghan BC Feldman E Liu J et al.

Source: Diabetes Care. Mar2011, Vol. 34 Issue 3, p635-640. 6p.

Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Authors: Calles-Escandón J Lovato LC Simons-Morton DG et al.

Source: Diabetes Care. Apr2010, Vol. 33 Issue 4, p721-727. 7p.

From Glucose to Limb Salvage: New Therapeutic Frontiers to Redefine Outcomes in Diabetic Foot Disease.

Authors: Dove C Pop-Busui R

Source: Diabetes care [Diabetes Care] 2026 May 01; Vol. 49 (5), pp. 709-710.

Publication Type: Editorial; Comment

Journal Info: Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE; In Process

Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes: A Secondary Analysis of the SOUL Randomized Clinical Trial.

Authors: Pop-Busui R Rasmussen S Deanfield JE et al.

Corporate Authors: Pop-Busui R Rasmussen S Deanfield JE et al.

Source: JAMA internal medicine [JAMA Intern Med] 2026 Apr 01; Vol. 186 (4), pp. 426-436.

Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589534 Publication Model: Print Cited Medium: Internet ISSN: 2168-6114 (Electronic) Linking ISSN: 21686106 NLM ISO Abbreviation: JAMA Intern Med Subsets: MEDLINE

Response to comments on Pop-Busui et al. Screening Natriuretic Peptide Levels Predicts Heart Failure and Death in Individuals With Type 1 and Type 2 Diabetes Without Known Heart Failure. Diabetes Care 2025;48:2145-2153.

Authors: Pop-Busui R Repetto E Baron J et al.

Source: Diabetes care [Diabetes Care] 2026 Mar 01; Vol. 49 (3), pp. e64-e65.

Publication Type: Letter

Journal Info: Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE; In Process

Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial.

Authors: Mann JFE Marx N Deanfield JE et al.

Corporate Authors: Mann JFE Marx N Deanfield JE et al.

Source: Diabetes care [Diabetes Care] 2026 Feb 01; Vol. 49 (2), pp. 257-265.

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE

Screening Natriuretic Peptide Levels Predicts Heart Failure and Death in Individuals With Type 1 and Type 2 Diabetes Without Known Heart Failure.

Authors: Pop-Busui R Repetto E Baron J et al.

Source: Diabetes care [Diabetes Care] 2025 Dec 01; Vol. 48 (12), pp. 2145-2153.

Publication Type: Journal Article

Journal Info: Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE